271 related articles for article (PubMed ID: 29124981)
1. Chitosan and its derivatives as vehicles for drug delivery.
Huang G; Liu Y; Chen L
Drug Deliv; 2017; 24(sup1):108-113. PubMed ID: 29124981
[TBL] [Abstract][Full Text] [Related]
2. Effects of Chemical Conjugation of l-Leucine to Chitosan on Dispersibility and Controlled Release of Drug from a Nanoparticulate Dry Powder Inhaler Formulation.
Muhsin MD; George G; Beagley K; Ferro V; Wang H; Islam N
Mol Pharm; 2016 May; 13(5):1455-66. PubMed ID: 26998555
[TBL] [Abstract][Full Text] [Related]
3. Chitosan/sulfobutylether-β-cyclodextrin nanoparticles as a potential approach for ocular drug delivery.
Mahmoud AA; El-Feky GS; Kamel R; Awad GE
Int J Pharm; 2011 Jul; 413(1-2):229-36. PubMed ID: 21540097
[TBL] [Abstract][Full Text] [Related]
4. Modified thermoresponsive Poloxamer 407 and chitosan sol-gels as potential sustained-release vaccine delivery systems.
Kojarunchitt T; Baldursdottir S; Dong YD; Boyd BJ; Rades T; Hook S
Eur J Pharm Biopharm; 2015 Jan; 89():74-81. PubMed ID: 25481034
[TBL] [Abstract][Full Text] [Related]
5. Transport mechanism of chitosan-N-acetylcysteine, chitosan oligosaccharides or carboxymethyl chitosan decorated coumarin-6 loaded nanostructured lipid carriers across the rabbit ocular.
Li J; Tan G; Cheng B; Liu D; Pan W
Eur J Pharm Biopharm; 2017 Nov; 120():89-97. PubMed ID: 28867370
[TBL] [Abstract][Full Text] [Related]
6. Chitosan-based gastroretentive floating drug delivery technology: an updated review.
Pahwa R; Saini N; Kumar V; Kohli K
Expert Opin Drug Deliv; 2012 May; 9(5):525-39. PubMed ID: 22444200
[TBL] [Abstract][Full Text] [Related]
7. Advances in chitosan-based drug delivery vehicles.
Hu L; Sun Y; Wu Y
Nanoscale; 2013 Apr; 5(8):3103-11. PubMed ID: 23515527
[TBL] [Abstract][Full Text] [Related]
8. Recent advancement of chitosan-based nanoparticles for oral controlled delivery of insulin and other therapeutic agents.
Chaudhury A; Das S
AAPS PharmSciTech; 2011 Mar; 12(1):10-20. PubMed ID: 21153572
[TBL] [Abstract][Full Text] [Related]
9. Application of Chitosan and its Derivatives in Nanocarrier Based Pulmonary Drug Delivery Systems.
Dua K; Bebawy M; Awasthi R; Tekade RK; Tekade M; Gupta G; De Jesus Andreoli Pinto T; Hansbro PM
Pharm Nanotechnol; 2017; 5(4):243-249. PubMed ID: 28786352
[TBL] [Abstract][Full Text] [Related]
10. Nanocrystals embedded in chitosan-based respirable swellable microparticles as dry powder for sustained pulmonary drug delivery.
Ni R; Zhao J; Liu Q; Liang Z; Muenster U; Mao S
Eur J Pharm Sci; 2017 Mar; 99():137-146. PubMed ID: 27988327
[TBL] [Abstract][Full Text] [Related]
11. Novel amphiphilic chitosan nanocarriers for sustained oral delivery of hydrophobic drugs.
Motiei M; Kashanian S
Eur J Pharm Sci; 2017 Mar; 99():285-291. PubMed ID: 28057549
[TBL] [Abstract][Full Text] [Related]
12. Glycyrrhizin conjugated chitosan nanoparticles for hepatocyte-targeted delivery of lamivudine.
Mishra D; Jain N; Rajoriya V; Jain AK
J Pharm Pharmacol; 2014 Aug; 66(8):1082-93. PubMed ID: 24641311
[TBL] [Abstract][Full Text] [Related]
13. Cytocompatible chitosan-graft-mPEG-based 5-fluorouracil-loaded polymeric nanoparticles for tumor-targeted drug delivery.
Antoniraj MG; Ayyavu M; Henry LJK; Nageshwar Rao G; Natesan S; Sundar DS; Kandasamy R
Drug Dev Ind Pharm; 2018 Mar; 44(3):365-376. PubMed ID: 28835136
[TBL] [Abstract][Full Text] [Related]
14. Chitosan mediated targeted drug delivery system: a review.
Patel MP; Patel RR; Patel JK
J Pharm Pharm Sci; 2010; 13(4):536-57. PubMed ID: 21486530
[TBL] [Abstract][Full Text] [Related]
15. Chitosan Nanoparticles as a Novel Drug Delivery System: A Review Article.
Matalqah SM; Aiedeh K; Mhaidat NM; Alzoubi KH; Bustanji Y; Hamad I
Curr Drug Targets; 2020; 21(15):1613-1624. PubMed ID: 32651965
[TBL] [Abstract][Full Text] [Related]
16. Thiolated chitosan nanoparticles for the nasal administration of leuprolide: bioavailability and pharmacokinetic characterization.
Shahnaz G; Vetter A; Barthelmes J; Rahmat D; Laffleur F; Iqbal J; Perera G; Schlocker W; Dünnhaput S; Augustijns P; Bernkop-Schnürch A
Int J Pharm; 2012 May; 428(1-2):164-70. PubMed ID: 22421322
[TBL] [Abstract][Full Text] [Related]
17. New Opportunity to Formulate Intranasal Vaccines and Drug Delivery Systems Based on Chitosan.
Popescu R; Ghica MV; Dinu-Pîrvu CE; Anuța V; Lupuliasa D; Popa L
Int J Mol Sci; 2020 Jul; 21(14):. PubMed ID: 32708704
[TBL] [Abstract][Full Text] [Related]
18. Nanoparticles for ocular drug delivery: modified and non-modified chitosan as a promising biocompatible carrier.
Pontillo ARN; Detsi A
Nanomedicine (Lond); 2019 Jul; 14(14):1889-1909. PubMed ID: 31274373
[TBL] [Abstract][Full Text] [Related]
19. Formulation, optimization and characterization of cationic polymeric nanoparticles of mast cell stabilizing agent using the Box-Behnken experimental design.
Gajra B; Patel RR; Dalwadi C
Drug Dev Ind Pharm; 2016; 42(5):747-57. PubMed ID: 26559522
[TBL] [Abstract][Full Text] [Related]
20. Positively Charged Nanostructured Lipid Carriers and Their Effect on the Dissolution of Poorly Soluble Drugs.
Choi KO; Choe J; Suh S; Ko S
Molecules; 2016 May; 21(5):. PubMed ID: 27213324
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
